Trials / Terminated
TerminatedNCT05365399
Evaluation of a Smartphone-based Screening Tool for Neonatal Jaundice in a Ugandan Population
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Picterus AS · Industry
- Sex
- All
- Age
- 24 Hours – 14 Days
- Healthy volunteers
- Accepted
Summary
The general objective of this study is to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at HICH Mbarara.
Detailed description
The general objective of this study is to evaluate the accuracy of a novel smartphone application that estimates bilirubin levels in newborns at HICH Mbarara. The specific objectives for this study are: To evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin measurements in serum in newborns with varying degree of jaundice To evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin estimates from a standard transcutaneous device in newborns with varying degree of jaundice To evaluate the correlation between bilirubin estimates from a smartphone application and bilirubin estimates from visual inspection in newborns with varying degree of jaundice
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | smartphone-based screening tool for neonatal jaundice | In this study we aim to collect data of newborns with wider range of bilirubin levels and high melanin content, and additionally measurements of skin color reflectance with a spectrophotometer, to adjust the Picterus JP algorithm and optimize the app performance. This will enable a high qualitative estimation of bilirubin levels in the blood of new-borns for all skin colors. . |
Timeline
- Start date
- 2022-05-03
- Primary completion
- 2022-08-15
- Completion
- 2022-08-15
- First posted
- 2022-05-09
- Last updated
- 2024-04-04
Locations
1 site across 1 country: Uganda
Source: ClinicalTrials.gov record NCT05365399. Inclusion in this directory is not an endorsement.